These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8458102)

  • 1. Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men.
    Lahlou N; Le Nestour E; Chanson P; Seret-Bégué D; Bouchard P; Roger M; Warnet A
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):301-9. PubMed ID: 8458102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro secretion of FSH by cultured clinically nonfunctioning and gonadotroph pituitary adenomas is directly correlated with locally produced levels of activin A.
    Wessels HT; Hofland LJ; van der Wal R; van Gastel L; van Koetsveld PM; de Herder WW; de Jong FH
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):485-92. PubMed ID: 11318784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibin concentrations in ovarian and jugular venous plasma and the relationship of inhibin with follicle-stimulating hormone and luteinizing hormone during the ovine estrous cycle.
    Findlay JK; Clarke IJ; Robertson DM
    Endocrinology; 1990 Jan; 126(1):528-35. PubMed ID: 2104590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotroph adenoma with secondary hypersecretion of testosterone.
    Chamoun R; Layfield L; Couldwell WT
    World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin activity in the mare and stallion.
    Roser JF; McCue PM; Hoye E
    Domest Anim Endocrinol; 1994 Jan; 11(1):87-100. PubMed ID: 8124933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotroph cell adenomas of the pituitary.
    Snyder PJ
    Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
    Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro.
    Daniels M; Newland P; Dunn J; Kendall-Taylor P; White MC
    J Endocrinol; 1988 Sep; 118(3):491-6. PubMed ID: 2460576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas.
    Chanson P; Lahlou N; Warnet A; Roger M; Sassolas G; Lubetzi J; Schaison G; Bouchard P
    J Endocrinol Invest; 1994 Feb; 17(2):91-8. PubMed ID: 8006338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between gonadotrophins, inhibin and sex steroid secretion during the periovulatory period and the luteal phase in the blue fox (Alopex lagopus).
    Mondain-Monval M; Farstad W; Smith AJ; Roger M; Lahlou N
    J Reprod Fertil Suppl; 1993; 47():47-56. PubMed ID: 8229964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone.
    Galway AB; Hsueh AJ; Daneshdoost L; Zhou MH; Pavlou SN; Snyder PJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):907-12. PubMed ID: 2119391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gonadotroph pituitary adenomas].
    Chanson P
    Ann Endocrinol (Paris); 2000 Sep; 61(3):258-68. PubMed ID: 10970952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of gonadotroph adenomas in women.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of follicle-stimulating hormone secretion by estradiol and dimeric inhibins in the infantile female rat.
    Herath CB; Yamashita M; Watanabe G; Jin W; Tangtrongsup S; Kojima A; Groome NP; Suzuki AK; Taya K
    Biol Reprod; 2001 Dec; 65(6):1623-33. PubMed ID: 11717121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH-, PRL-, POMC-, beta-TSH-, beta-LH-, beta-FSH-mRNA in gonadotroph adenomas of the pituitary by in situ hybridization in comparison with immunostaining and clinical data.
    Münscher A; Schmid M; Saeger W; Schreiber S; Lüdecke DK
    Endocr Pathol; 2001; 12(2):171-80. PubMed ID: 11579683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion.
    Snyder PJ; Muzyka R; Johnson J; Utiger RD
    J Clin Endocrinol Metab; 1980 Oct; 51(4):744-8. PubMed ID: 6774992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of catalyzed signal amplification in immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas.
    Sanno N; Teramoto A; Sugiyama M; Itoh Y; Osamura RY
    Am J Clin Pathol; 1996 Jul; 106(1):16-21. PubMed ID: 8701926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein hormone alpha-subunit secretion in prolactinomas and in non-functioning adenomas: relation with the tumour size.
    Warnet A; Porsova-Dutoit I; Lahlou N; Seret-Begue D; Lajeunie E; Chanson P; Woimant F; Lot G; Guillausseau PJ; Roger M
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):177-84. PubMed ID: 7523001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum FSH bioactivity and inhibin levels in patients with gonadotropin secreting and nonfunctioning pituitary adenomas.
    Borgato S; Persani L; Romoli R; Cortelazzi D; Spada A; Beck-Peccoz P
    J Endocrinol Invest; 1998 Jun; 21(6):372-9. PubMed ID: 9699129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
    MacNaughton J; Banah M; McCloud P; Hee J; Burger H
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.